Sarat Chander - Concepedia

Author

Sarat Chander

Peter MacCallum Cancer Centre ORCID

Also Known As

Chander, S., S CHANDER, S Chander, S Sarat Chander, S. Chander, S.Sarat Chander, Sarat Chander

124

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Peter MacCallum Cancer Centre The University of Melbourne Sunnybrook Health Science Centre University of Toronto St Vincent's Hospital Melbourne

About

Sarat Chander is an author at Peter MacCallum Cancer Centre specializing in medicine, radiation oncology, and radiation therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.5K
2	Health Sciences	7	7	453
3	Gastroenterology	2	2	290
4	Emergency Medicine	1	1	12
5	Endocrinology	1	1	18

Sarat Chander

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial Shankar Siva, Mathias Bressel, Declan G. Murphy, European Urology Adaptive RadiotherapyUrologySurgical OncologyRadiation TherapyMedicine	2018	313
Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer Michael Ng, Trevor Leong, Sarat Chander, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyContouring AtlasPlanning GuidelinesRadiation TherapyMedical Imaging	2012	221
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy Elise De Bleser, Barbara Alicja Jereczek‐Fossa, Thomas Zilli, European Urology Surgical OncologyUrologyRadiation TherapyMetastasis-directed TherapyMedicine	2019	137
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial Shankar Siva, Mathias Bressel, Simon Wood, European Urology Short-course PembrolizumabUrologySurgical OncologyRadiation TherapyGenitourinary Cancer	2021	132
High-Dose-Rate Brachytherapy as a Monotherapy for Favorable-Risk Prostate Cancer: A Phase II Trial Maroie Barkati, Scott Williams, Farshad Foroudi, International Journal of Radiation OncologyBiologyPhysics UrologyPhase Ii TrialRadiation TherapyMedicineBrachytherapy	2011	118
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial Shankar Siva, Daniel Pham, Tomas Kron, British Journal of Urology	2017	116
Direct 2-Arm Comparison Shows Benefit of High-Dose-Rate Brachytherapy Boost vs External Beam Radiation Therapy Alone for Prostate Cancer Richard Khor, Gillian Duchesne, Keen‐Hun Tai, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyMedicineBrachytherapyOncology	2012	97
Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy Suki Gill, Jessica Thomas, Chris Fox, Radiation Oncology	2011	97
Twenty-Five-Year Experience With Radical Chemoradiation for Anal Cancer Jonathan M. Tomaszewski, Emma Link, Trevor Leong, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineAnal CancerOncologyRadiation Oncology	2011	83
Pilot Study: Potential Role of Vitamin D (Cholecalciferol) in Patients With PSA Relapse After Definitive Therapy Tony Woo, Richard Choo, Mary J Jamieson, Nutrition and Cancer	2005	80

Page 1